Exane Derivatives’s Ovintiv OVV Stock Holding History

Exane Derivatives’s Portfolio OVV Stock Details OVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-293	Closed	-$9.87K	–	1072
2021 Q4	$9.87K	Hold	293	–	–	﹤0.01%	591
2021 Q3	$9.63K	Hold	293	–	–	﹤0.01%	709
2021 Q2	$8.82K	Hold	293	–	–	﹤0.01%	749
2021 Q1	$6.98K	Hold	293	–	–	﹤0.01%	609
2020 Q4	$4.21K	Hold	293	–	–	﹤0.01%	570
2020 Q3	$2.39K	Hold	293	–	–	﹤0.01%	551
2020 Q2	$2.8K	Hold	293	–	–	﹤0.01%	486
2020 Q1	$791	Hold	293	–	–	﹤0.01%	555
2019 Q4	$6.24K	Hold	293	–	–	﹤0.01%	424
2019 Q3	$6.72K	Sell	293 -707	-71%	-$16.2K	﹤0.01%	443
2019 Q2	$25.7K	Hold	1,000	–	–	﹤0.01%	417
2019 Q1	$36.3K	Hold	1,000	–	–	0.01%	354
2018 Q4	$28.9K	Hold	1,000	–	–	0.01%	416
2018 Q3	$65.8K	Hold	1,000	–	–	0.01%	358
2018 Q2	$65.5K	Hold	1,000	–	–	0.01%	368
2018 Q1	$55.5K	Hold	1,000	–	–	0.01%	343
2017 Q4	$66.9K	Hold	1,000	–	–	0.01%	325
2017 Q3	$59K	Hold	1,000	–	–	0.01%	296
2017 Q2	$44K	Hold	1,000	–	–	0.01%	324
2017 Q1	$57.6K	Hold	1,000	–	–	0.01%	257
2016 Q4	$58.5K	Buy	+1,000	New	+$57K	0.01%	285

Other funds holding OVV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Exane Derivatives's OVV Position: Q1 2022 in Review

Exane Derivatives sold out of Ovintiv (OVV) in Q1 2022, closing a stake of 293 shares — an estimated $9.87K sold.

Exane Derivatives first reported a position in OVV in Q4 2016 and held it in 21 quarters. The position peaked at $66.9K in Q4 2017. 408 funds tracked by Wall St. Rank hold OVV as of Q1 2022.

Exane Derivatives reported no remaining Ovintiv position as of Q1 2022 after selling out during the quarter.
Exane Derivatives sold 293 Ovintiv shares in Q1 2022, an estimated $9.87K.
Exane Derivatives first reported a position in Ovintiv in Q4 2016 and held it in 21 quarters.
Exane Derivatives's Ovintiv position peaked at $66.9K in Q4 2017.
408 funds tracked by Wall St. Rank held Ovintiv as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.